Archives
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
ARCA EGFP mRNA (5-moUTP): Benchmarking Reporter mRNA for ...
2025-09-27
Explore how ARCA EGFP mRNA (5-moUTP) redefines direct-detection reporter mRNA tools by integrating stability, innate immune suppression, and superior fluorescence-based assay performance. This article uniquely benchmarks its translational applications and storage resilience, offering advanced insights for mRNA transfection in mammalian cells.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Transforming Cancer Resea...
2025-09-26
Explore how EZ Cap™ Human PTEN mRNA (ψUTP) enables next-generation cancer research by precisely modulating the PI3K/Akt signaling pathway. This in-depth analysis details its mechanism, advanced delivery, and immunological benefits, setting it apart from previous studies.
-
RSL3 and Ferroptosis: Redefining Cancer Cell Death Pathways
2025-09-25
Explore how RSL3, a potent glutathione peroxidase 4 inhibitor, enables advanced dissection of ferroptosis and iron-dependent cell death in cancer research. This article uniquely connects RSL3’s mechanistic action with emerging insights on non-apoptotic and apoptotic pathways, offering a deeper perspective on redox vulnerabilities and therapeutic innovation.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Next-Gen Control for Precision G...
2025-09-24
Explore how EZ Cap™ Cas9 mRNA (m1Ψ) sets a new standard for capped Cas9 mRNA in genome editing, with advanced control over specificity and immune evasion. Discover unique mechanistic insights and translational strategies not covered in prior reviews.
-
Pseudo-UTP: Mechanistic Insights for mRNA Synthesis and I...
2025-09-23
Explore the mechanistic basis for using Pseudo-modified uridine triphosphate (Pseudo-UTP) in mRNA synthesis, focusing on RNA stability, translation efficiency, and reduced immunogenicity. This article delves into recent scientific findings and practical guidance for mRNA vaccine and gene therapy applications.
-
This chemistry paved way for
2025-03-03

This chemistry paved way for multi-gram synthesis of which was utilized for extensive piperazine benzamide SAR exploration. Depicted in , the two-step operation towards final targets involved standard amide coupling conditions with EDC or HATU followed by Boc deprotection under acidic conditions. S
-
The role of DHT in early teleost embryogenesis is
2025-03-03

The role of DHT in early teleost embryogenesis is not entirely clear or established, however additional studies that treat fish embryos to DHT or to specific srd5a inhibitors at critical stages of development (i.e. prior to sex differentiation) will shed light on the early functions of this androgen
-
br Methods br Results and discussion br Conclusions br Ackno
2025-03-03

Methods Results and discussion Conclusions Acknowledgements The authors thank Dr. Francois Alhenc-Gelas (then INSERM U367, Paris, France), who kindly provided the plasmid for truncated soluble recombinant human ACE – WTΔ, Dr. Elena Arablinskaya (Institute of Phtiziopulmonology, Moscow, R
-
As mentioned above variation of the A
2025-03-03

As mentioned above, variation of the A-ring was undertaken in order to improve microsomal stability and kinase selectivity relative to ASK1 inhibitor (). 1-Imidazole-2-carboxamides with substitution at the 4-position (–) were mostly tolerated with 4-cyano-imidazole-2-carboxamide () having comparabl
-
Autophagy is a highly conservative intracellular bulk degrad
2025-03-03

Autophagy is a highly conservative intracellular bulk degradation process including three major forms namely microautophagy, chaperone-mediated autophagy and macroautophagy. A large number of evidence has depicted a pivotal role for autophagy in the maintenance of cardiac geometry and contractile fu
-
Our data indicate that the D domain only needs
2025-03-03

Our data indicate that the D1 domain only needs to hydrolyze ATP a few times, or perhaps even just once, during the processing of a given substrate molecule, whereas the D2 domain hydrolyzes ATP many times. Consistent with this model, only D2 contains the canonical aromatic pore loop residues implic
-
Coincident with APJ receptor several cell
2025-03-01

Coincident with APJ receptor, several cell types in the body can synthesize apelin protein. For example, the highest apelin concentrations in the body have been found in the rat central nervous system, pituitary gland, lungs, cardiac muscle, gastrointestinal tract and mammary glands, with lower val
-
mitotane Furthermore a recently published network meta analy
2025-03-01

Furthermore, a recently published network meta-analysis including 30 trials in patients with hypertension and diabetes demonstrated that ARBs have efficacy similar to that of ACEIs for all-cause and cardiovascular mortality (HR 0.95, 95% CI 0.73 to 1.30 and HR 1.23, 95% CI 0.64 to 2.78, respectively
-
br Role of AMPK in inflammation signaling Pro inflammatory c
2025-03-01

Role of AMPK in inflammation signaling Pro-inflammatory cytokines, such as interleukin (IL)-6 and tumor necrosis factor-α (TNF-α), activate Ikβ kinase (IKKβ), which phosphorylates IκBα, triggering the degradation of proteasomal IκB. This liberates active nuclear factor kB (NF-kB) to translocate i
-
Alectinib is a second generation ALK antagonist
2025-03-01

Alectinib is a second generation ALK antagonist that is built upon a 9-ethyl-6, 6-dimethyl-11-oxo benzo[b]carbazole scaffold (Fig. 5C) [58]. This drug is effective against the ALK L1196M gatekeeper mutation along with C1156Y and F1174L mutations [7]. The 11-oxo group of the drug forms a PCI32765 wi
16016 records 9/1068 page Previous Next First page 上5页 678910 下5页 Last page